Wilfried Le Goff (INSERM, Sorbonne Université)ObesityMembrane target triggers inflammationResearchers at Sorbonne Paris have discovered that a membrane protein in adipocytes of obese mice and humans changes the lipid composition of adipose tissue macrophages rendering them more inflammatory … more ➔
SLASAutomation & Drug ScreeningEuropean Biotechnology and SLAS seal partn...The Society for Laboratory Automation & Screening (SLAS) has selected the European Biotechnology Magazine as its official media partner. more ➔
SLAS - Alexandra Csuport PhotographyLab Automation & ScreeningBiopharma transformation: growing impact o...New AI tools and drug screening based on human cells and organoids promise a quantum leap in the success rate of drug development and in the processing of data from high-throughput analyses as well as … more ➔
EuroscreenFastAequorin TechnologyAequorin: superior choice for GPCR calcium...The study of G protein-coupled receptor (GPCR) signalling is crucial for understanding a wide range of physiological processes. Among the methods used to monitor calcium signalling, Aequorin stands … more ➔
VALIDOGENBioprocess DevelopmentPichia protein productionRecombinant protein production in Pichia typically relies on AOX1 promoter-driven expression using methanol for induction. However, some companies avoid methanol due to safety concerns or operational … more ➔
Tebubio SASmRNA ProductionYour mRNA Partner in EuropeMessenger RNA (mRNA) has gained significant attention since being used in the Pfizer-BioNTech and Moderna COVID-19 vaccines. mRNA holds potential for preventing and treating many difficult-to-treat or … more ➔
Jeremy Levin, Ovid TherapeuticsBiosecure actThe West’s wake-up call to China’s bio...The U.S. House of Representatives recently passed the BIOSECURE Act, prohibiting U.S. biopharma companies from working with Chinese contractors due to national security concerns, including data leaks … more ➔
Synthetic biologyBiology as SoftwareAt a recent event researcher and founder of Bit.bio, Prof. Mark Kotter, Babraham Research Campus in Cambridge/UK, was asked what healthcare looks like in 2050. He gave a twofold answer, that it will … more ➔
BiomanufacturingRichter-Helm – how CDMOs become stro...Professionalism and quality are always at the forefront along the whole value chain: from gene to product. To pro-actively meet the evolving demand of the market to produce new assets Richter-Helm significantly … more ➔
BiomanufacturingA novel BPM systemThe biotech and pharma branch is growing steadily. Many companies have full order books for the next few years and expect growth. This is the basis for new investments in assets and infrastructure. These … more ➔
Wilfried Le Goff (INSERM, Sorbonne Université)
SLAS
SLAS - Alexandra Csuport Photography
EuroscreenFast
VALIDOGEN
Tebubio SAS
Jeremy Levin, Ovid Therapeutics
